Polyomavirus large T antigen binds to two sites located between positions -110 and -170 of a human heat shock protein 70 (hsp70) promoter. Methylation interference studies show that binding for each site is determined by two GPuGGC pentanucleotide sequences. The specificity of this binding interaction is similar to that observed for large T binding to the viral genome. The existence of sequences that bind a viral protein in a cellular promoter raises the possibility that these sequences play a role in gene expression in an uninfected cell. We show that hsp70 large T antigen binding site 1 is capable of functioning as an upstream promoter element in cells that do not contain any viral T antigen. Genetic analysis of this effect suggests that a cellular factor exists that has a binding specificity that overlaps but is not identical to that of polyomavirus large T antigen. To determine whether binding of polyomavirus large T antigen can regulate expression of the intact human hsp70 promoter, we have introduced the promoter into mouse cells with plasmids that express the polyomavirus early proteins. These proteins stimulate the level of correctly initiated hsp70 transcripts, but surprisingly the degree of stimulation remains unchanged for promoter constructs in which the large T antigen binding sites have been deleted. These observations suggest that trans activation of the hsp70 promoter by the polyomavirus early proteins occurs through protein-protein interactions and not through sequence-specific DNA binding.
Polyomavirus large T antigen binds to two sites located between positions -110 and -170 of a human heat shock protein 70 (hsp70) promoter. Methylation interference studies show that binding for each site is determined by two GPuGGC pentanucleotide sequences. The specificity of this binding interaction is similar to that observed for large T binding to the viral genome. The existence of sequences that bind a viral protein in a cellular promoter raises the possibility that these sequences play a role in gene expression in an uninfected cell. We show that hsp70 large T antigen binding site 1 is capable of functioning as an upstream promoter element in cells that do not contain any viral T antigen. Genetic analysis of this effect suggests that a cellular factor exists that has a binding specificity that overlaps but is not identical to that of polyomavirus large T antigen. To determine whether binding of polyomavirus large T antigen can regulate expression of the intact human hsp70 promoter, we have introduced the promoter into mouse cells with plasmids that express the polyomavirus early proteins. These proteins stimulate the level of correctly initiated hsp70 transcripts, but surprisingly the degree of stimulation remains unchanged for promoter constructs in which the large T antigen binding sites have been deleted. These observations suggest that trans activation of the hsp70 promoter by the polyomavirus early proteins occurs through protein-protein interactions and not through sequence-specific DNA binding. Polyomavirus, simian virus 40 (SV40), and adenovirus are all double-stranded DNA tumor viruses which encode proteins capable of establishing primary cells in culture. For each virus the genes responsible for this immortalization function have been identified (25. 45, 48) . In all cases the gene products are nuclear antigens. Polyomavirus large T and SV40 large T antigens are sequence-specific DNAbinding proteins (20, 52, 53) . Both the adenovirus Ela region and SV40 large T antigen have been shown to be capable of stimulating transcription in tr-anis from viral promoters as well as from some transfected cellular promoters (1, 4, 6-8, 21, 24, 30, 32, 33) . Other viruses capable of establishing primary cells in culture contain genes that encode nuclear proteins that share this ability to trants activate promoters, leading to the hypothesis that an ability to regulate cellular promoters is necessary for immortalization activity (reviewed in reference 36). One prediction of this hypothesis is that immortalizing gene products will directly interact with cellular promoter regions to either repress or activate those promoters.
One promoter that immortalizing gene products might regulate is the human heat shock protein 70 (hsp70) promoter. The promoter is activated during adenovirus infection, and hsp70 gene expression is elevated in some tumor cell lines as well as in SV40-infected cells (27, 31, 34, 43, 57a) . The c-myc gene product, a cellular protein capable of immortalizing cells, is capable of stimulating expression from a Drosophilac melanogaster lhsp70 promoter region (35) . In addition, the hsp70 protein is strongly conserved from bacteria to humans, suggesting that it plays a fundamental * Corresponding author.
role during normal cellular growth (2, 26) . Deletion of this gene in Saccharonmyces cerevisiae results in impaired growth at normal temperatures, implying that this protein has a function independent of its role in protecting cells from stress (13, 14) .
There are several loci that encode the hsp70 protein or related proteins in all eucaryotic organisms characterized to date. The human genome encodes at least five loci. The coding region of the human gene studied in this work has a high degree of homology to both the Drosophila hsp70 gene and to Escherichia coli dnaK, identifying it as a member of the hsp7O family (26, 57) . Although there is a high constitutive level of the mRNA for this gene in HeLa cells, RNA levels remain heat inducible. The promoter contains a sequence between -93 and -107 that is homologous to the consensus heat shock regulatory sequence found in Drosophila hsp70 promoters. Deletion analysis is consistent with this element alone being responsible for heat inducibility (58) . The promoter is induced when fresh serum is added to resting cells (59) , and the sequences responsible for serum stimulation lie within 58 nucleotides of the transcription start site (58) .
We have determined the ability of the polyomavirus early region proteins to interact with this human hsp7O promoter. The polyomavirus early region encodes three proteins, termed large, middle, and small T antigens. Large T antigen is capable of immortalizing primary cells in culture, while middle T antigen is required for full transformation of cells (47, 48, 54 (23) . DNA (10 to 12 p.g total) was ethanol precipitated and suspended in 0.5 ml of 250 mM CaCI2. A 0.5-ml amount of 2x HeBS was bubbled while the DNA solution was added dropwise. The precipitate was immediately vortexed for 5 min and allowed to sit at room temperature for 20 min. This solution was then added to a 10-cm dish of cells at 20% confluence that had been fed with fresh DME 2 h earlier. After 16 h, the cells were washed with phosphate-buffered saline and fed with fresh medium. Cells were harvested for either RNA or protein 36 to 48 h after removing the precipitate.
Plasmids. All plasmid DNAs were purified by banding twice with ethidium bromide-CsCl gradient centrifugation. DNA concentrations were determined spectrophotometrically and were verified by agarose gel electrophoresis. Construction of the 5' deletion series into the human hsp7O promoter (pA plasmids) has been described previously (58) , as has plasmid pXGH5 (Sla). Other constructions were as follows. pyLT and py3T were the generous gift of Parmjit Jat (28) . They were constructed by insertion of a BglI-BamHl fragment (nucleotides [nt] 87-4633 of polyomavirus) containing either a wild-type polyomavirus early region or a large T cDNA (48) into the unique BamHI site of pZipNeoSV(X)I (9).
Plasmid pIR17 (John Greene, this laboratory) was made by partial digestion of plasmid pA1250 with PstI, isolation of the resultant linears, resection with Bal3l, and ligation. The plasmid contains a 33-bp deletion extending from +65 to +98 of the hsp7O 5' untranslated region.
Plasmids in the pA58+ series were made by opening the plasmid pA58 with HindIll and ligating the appropriate nonphosphorylated 25-mer duplex at a 100:1 molar excess. 1 ,ug/ml, heated at 65°C for 5 min to melt inappropriately hybridized oligonucleotides, and slowly cooled to promote recircularization before transfer into E. coli.
All hsp7O promoter deletions and variants were sequenced by the primed synthesis method (50) . Templates for sequencing were prepared by irreversible alkali denaturation of the double-stranded plasmids (10) .
RNA preparation and analysis. Total cellular RNA was prepared by the guanidinium-CsCl method (39, 55) . Singlestranded end-labeled probes were prepared as follows. A single-stranded 20-mer (0.1 ,ug) homologous to the coding sequence of chloramphenicol acetyltransferase (CAT; CAA-CGG-TGG-TAT-ATC-CAG-TG) was kinased with 32P and hybridized to single-stranded DNA (20 Determination of CAT and growth hormone expression levels. CAT extracts were prepared and assayed by standard procedures (22) . At the time of harvest for CAT assay, medium was removed from the dishes for determination of growth hormone levels. These samples were assayed by a sandwich radioimmunoassay assay with a commercially available kit (Tandem). Growth hormone levels were within the linear range of the assay as determined by using premixed standards.
RESULTS
Large T antigen binding sites. We were prompted to evaluate the ability of polyomavirus large T antigen to bind to the human hsp7O promoter by initial observations that the polyomavirus early region could trans activate the promoter in cotransfection assays (see below). We investigated binding with plasmid pA1250, which contains bases -1250 to +160 of this promoter (Fig. 1 ). An end-labeled restriction digest of this plasmid was incubated with purified polyomavirus large T antigen, and DNA that bound this antigen was precipitated with monoclonal antibody against large T antigen. A fragment containing sequence from + 160 to -1250 of the human hsp70 promoter was specifically immunoprecipitated (Fig. 1, lane A) significantly diminished this interaction (lane E). Inspection of the sequence between -189 and -68 revealed four copies of the sequence GPuGGc. This sequence is known to specify binding to polyomavirus large T antigen (12, 46) . We wished to more accurately characterize the T antigen binding interaction to determine whether in this instance it was specified by these sequences.
DNase I protection studies and methylation interference studies were used to further define the large T binding sites. End-labeled DNA fragments spanning the promoterproximal region were incubated with various amounts of purified polyomavirus large T antigen and subjected to limited DNase digestion. Two separate sites were protected from DNase digestion ( Fig. 2A and B, left panels) . This protection was seen when either DNA strand was end labeled and used as probe. These sites were located between bases -110 and -170 of the promoter and are referred to as sites 1 (promoter proximal) and 2 (Fig. 3) .
Guanine N-7 methylation in the T antigen recognition sequence results in inhibition of the binding of either SV40 or polyomavirus large T antigen to binding sites in their respective viral genomes (12, 29) . To characterize the human hsp7O T Ag (ng) T Ag (ng) binding sites, end-labeled DNA fragments containing both sites 1 and 2 were partially methylated and incubated with purified polyomavirus large T antigen, and the bound and free DNA segments were separated by monoclonal antibody precipitation as described above (Fig. 2) . Differences in the intensities of bands in the bound and free fractions were quantitated by scanning densitometry (Fig. 2C) Fig. 3 . Binding sites 1 and 2 both contained two copies of the pentanucleotide sequence GPuGGC previously shown to specify large T antigen binding. In site 1 these pentanucleotides were in direct orientation and separated by 7 base pairs (bp), while in site 2 the sequences with the best fit to the pentanucleotide sequence were in inverted orientation and separated by 9 bp.
We wished to quantitate the relative binding affinity of hsp7O site 1 for large T antigen. Using the immunoprecipitation procedure described above, we compared the binding affinity of T antigen for purified DNA fragments containing either 21 bases of hsp7O site 1 (from plasmid pA58+1, see Fig. 7 ), the polyomavirus site A, or the polyomavirus ori site (11) . The DNA fragments containing these sites all behaved similarly in this assay both in the absence of competitor DNA (Fig. 4A) and in the presence of competitor DNA (Fig.  4B) . These results argue that the relative binding affinity of polyomavirus large T antigen for hsp7O site 1 is similar to that of T antigen for individual sites in the polyomavirus genome. trans activation by polyomavirus T antigens. SV40 large T antigen has been shown to stimulate transcription from the SV40 late promoter as well as from several heterologous promoters (1, 6, 32) . Stimulation of the late promoter appears to be partly the result of T antigen binding to sequences in the SV40 origin, approximately 250 bp from the late transcription start sites (7, 8, 33) . These observations led us to investigate the ability of the polyomavirus early region to trans activate the human hsp7O promoter. To facilitate investigation of the regulation of this promoter, a plasmid was made containing bases -1250 to +160 of the hsp7O promoter region fused to the CAT gene (pA1250).
Polyomavirus early region proteins were expressed by using a construction containing the entire early region under control of the Maloney virus long terminal repeat (LTR) (py3T) (P. Jat, unpublished [9] ). Cotransfection of pA1250 with py3T resulted in a 5-to 20-fold stimulation of CAT activity (Tables 1 and 2 ; see also Fig. 5 ). To determine the sequence requirements for this effect, we investigated stimulation of a series of mutant plasmids containing various amounts of 5' flanking sequence. The activity from a deletion that retained only 58 bp upstream of the hsp7O initiation site was still significantly stimulated by cotransfection with py3T (Table 1 ). This deletion, while impaired in basal activity, retained the ability to promote transcription from the appropriate initiation site (see Fig. 7 ) (58) . These data argue that the T antigen binding sites are not necessary to observe stimulation. Due to the inherent variability of these experiments, however, they do not rule out a role for the T antigen binding sites in allowing maximal stimulation.
To address the issue of whether the T antigen binding sites contribute to stimulation of this promoter, we included a uniform amount of a reference plasmid (pXGH5) in each further experiment to control for transfection efficiency. Plasmid pXGH5 contains a human growth hormone gene fused to a mouse metallothionein I promoter region (Sla). Transfected cells secreted growth hormone into the media, and the amount was easily quantitated through use of a radioimmunoassay. Cotransfection with py3T increased both growth hormone expression from pXGH5 and CAT expression from pA1250. The level of CAT activity rose twoto threefold more than the level of growth hormone activity, suggesting that there is some preferential stimulation of the human hsp7O promoter relative to the mouse metallothionein I promoter ( Table 2) . Stimulation of CAT expression relative to stimulation of growth hormone expression remained constant as the two T antigen binding sites were removed (Table  2 ). These data suggest that stimulation of this promoter by the polyomavirus early region is largely independent of any sequence-specific binding of large T antigen.
We sought to determine the start site for hsp7O transcription in the presence and absence of the polyomavirus early region and to get a second determination of the role of T antigen binding sites in the observed stimulation. We therefore measured the level of correctly initiated transcripts from the hsp7O promoter in the presence and absence of polyomavirus early proteins. To control for the amount of trans activation in this experiment, we used a marked plasmid (pIR17) that contained a wild-type hsp7O promoter region with a 33-bp deletion in the 5' untranslated region of the mRNA (Fig. 5) . When pIR17 was transfected into BALB/c 3T3 cells and the resulting RNA was analyzed by S1
nuclease analysis with a probe from an unaltered hsp7O-CAT plasmid, a band of 129 bases resulted due to looping of the probe sequences opposite the deletion in the pIR17 message (Fig. 5, lane A) . All of the plasmids containing deletions into the 5' flanking sequence of the hsp7O promoter gave rise to an unaltered mRNA, which resulted in a band of 230 bases after S1 nuclease analysis (lane B). It was therefore possible to directly compare the degree of trans activation of these promoters with the trans activation of the promoter of pIR17 in a single experiment. By this analysis, the wild-type promoter (pA1250), a promoter containing only binding site 1 (pA133), and a promoter with no T antigen binding sites (pA107) were stimulated to an identical degree after cotransfection with py3T in comparison to the wild-type promoter of pIR17 (Fig. 5 ). This analysis also indicates that the level of mRNA observed correlated with the level of CAT activity and that this mRNA had the appropriate 5' end in both the presence and absence of trans activation.
The polyomavirus early region encodes three proteins: large, middle, and small T antigens. We wished to determine whether large T antigen alone was responsible for the observed stimulation. A plasmid expressing only large T antigen (pyLT) was identical to py3T except that it contained the large T antigen cDNA in place of the entire early region (28, 48) . When pyLT replaced py3T in cotransfection experiments, the degree of stimulation of the hsp7O promoter was lower. These results were obtained when expression was measured by either protein expression or RNA level, and pA1250 was stimulated only 1.5-fold more than pXGH5 (Table 2 and Fig. 5 ). These data suggest that polyomavirus large T plays a role in trans activation of the human hsp7O promoter but may not be entirely responsible for this effect.
T antigen binding site 1 functions as an upstream promoter element. The presence of T antigen binding sequences in a cellular promoter suggested the possibility that these sequences may be part of an upstream promoter element.
Deletion of these sequences did not significantly affect hsp7O promoter activity in BALB/c 3T3 cells (Fig. 5 and 7 ). This sequence is therefore not necessary for full basal levels of expression from the promoter when the promoter is contained on transfected DNA. However, deletion of the sequence 5'-GATTGGCTC-3' centered at -64 of the hsp7O promoter reduced basal levels of expression approximately fivefold (Table 1 and Fig. 7 ; compare pA68 and pA58) (58) . The complement to this sequence, GAGCCAATC, has strong homology to CAT box sequences necessary for full expression of the 3-globin promoter (18, 23a. 42a) . To test whether T antigen binding site 1 could function as a promoter element in a different setting, we inserted a 21-base sequence encompassing T antigen binding site 1 into the HindIll site of pAS58, replacing the CAT box with the sequence of binding site 1 (plasmid pA58+ 1). We determined the promoter activity of this construction by cotransfecting it with pXGH5 as an internal control. This insertion resulted in a three-to fourfold activation of the promoter (Fig. 6,  pA58+1) , suggesting that this sequence can function as an upstream promoter element.
We wished to ensure that the activation of the promoter was caused by the T binding sequences and not by some artifactual juxtaposition of sequences due to insertion of the oligomer. Four sets of mutants were made that differed from plasmid pA58+ 1 only in this 21-base sequence (Fig. 6) . Plasmids pA58+2 and pA58+3 both contained double point mutations that resulted in transversions of bases in the GPuGGC sequence, known to be involved in T antigen binding. Plasmid pA58+4 contained mutations in both GPuGGC elements. These mutants were impaired in their (8 ,ug) and py3T (1 jig); F, pAl107 (8 ,ug) and pyLT (1 pLg); G, pA107 (8 [Lg) ; H, pA107 (8 jig) and py3T (1 ,ug); I, pA1250 (8 ,ug); J, pA1250 and py3T (1 jig); K, pA107 (8 ,ug) ; L, pA107 (8 jig); and py3T (1 ,ug) . The diagram at the bottom shows the promoter regions of the plasmids used (arrow is at start site) and the expected lengths of protected fragments after S1 nuclease analysis. ability to bind large T antigen (data not shown). Plasmid pA58+5 had a set of changes that made the sequence identical to that of T antigen binding site 1 of SV40, a binding site that is recognized as efficiently by polyomavirus large T antigen as hsp7O site 1 (data not shown). All four mutants were significantly reduced in activity in BALB/c 3T3 cells compared with plasmid pA58+1 (Fig. 6) . The mutations of plasmids pA58+2 and pA58+3 both caused a twofold decrease in activity. The mutations in plasmids pA58+4 and pA58+5 both reduced activity to that of the starting plasmid, pQ58.
Results similar to those obtained with CAT expression were obtained by analyzing RNA level (Fig. 7) . Plasmid pIR17 was used as an internal control in these studies. The level of correctly initiated hsp7O transcript from plasmid pA58+1 was significantly higher than that from pA58, implying that hsp7O site 1 is indeed capable of functionally replacing the hsp7O CAT box. The artificial promoter of pA58+1 was only minimally weaker than the wild-type hsp7O promoter (Fig. 7, compare lanes D and E) . The data imply that the sequences responsible for activity of this artificial promoter overlap with those that are responsible for binding polyomavirus large T antigen. As there was no T antigen present in these experiments, the data suggest that a cellular protein has an overlapping but not identical binding specificity as that of polyomavirus large T antigen.
DISCUSSION
Role of T antigen binding in transcriptional stimulation. Two sets of observations led to the hypothesis that the large T antigens of the papovaviruses SV40 and polyomavirus may directly interact with cellular promoters. First, viral infection results in rapid changes in the spectrum of newly synthesized cellular proteins (40) . Second, these antigens in certain circumstances can confer an indefinite growth, or immortal, phenotype on primary cells which clearly entails changes in the pattern of expression of the cellular genome (45, 48) . Both antigens are localized primarily in the nucleus of cells. It has been reported that SV40 large T antigen mutants that are not transported to the nucleus do not immortalize primary baby rat kidney cells (38) . Although there are numerous roles that a protein can play in the nucleus to confer these phenotypes, one attractive hypothesis has been that these nuclear antigens directly modulate the activity of cellular promoters.
We have shown that polyomavirus large T antigen binds to two sites between 110 and 170 bases 5 (8 ,ug) was transfected with plasmid pXGH5 (2 ,ug). The value for relative expression was determined by correcting the level of CAT activity from the pA58 series plasmids for transfection efficiency as determined by growth hormone activity from pXGH5. In each experiment, pA58 activity was arbitrarily assigned a value of 1.0. ND, Not done.
initiation site of one of the human hsp7O genes. These binding sites have the canonical large T antigen binding sequence defined by studies on binding to the viral genome: two pentanucleotides of the sequence GPuGGC separated by approximately one turn of the DNA double helix (12) . We showed by methylation interference studies that large T antigen interacts with the predicted G residues in or adjacent to these pentanucleotide sequences in hsp7O binding site 1.
All of these G residues lie on one face of the DNA helix and promoter region by polyomavirus large T antigen. Expression of the entire early region of polyomavirus results in a 5-to 20-fold stimulation of the level of correctly initiated hsp7O transcripts (Fig. 5) . However, stimulation from the hsp7O start site is not noticeably altered by deletion of either or both of the hsp7O T antigen binding sites. The plasmids containing these mutant promoters contained no detectable T antigen binding sites (Fig. 1E) . Thus, the polyomavirus early region can activate this promoter in the apparent absence of sequence-specific binding of large T antigen. Expression from a hybrid gene containing the mouse metallothionein I promoter fused to the human growth hormone coding region was also activated by the polyomavirus early region, again suggesting that there is no strict sequence dependence for stimulation. Indirect activation of transcription has been seen with the gene products of the immortalizing regions of other DNA tumor viruses, notably the Ela region of adenovirus (24, 37, 42, 60) .
Previous data are consistent with the hypothesis that both the Ela proteins and SV40 large T antigen alter the function of general transcription factors in the cell (1, 7, 8, 33 ; reviewed in reference 36).
The data presented here argue that the polyomavirus early region proteins probably activate transcription by similar indirect means. Every tested deletion mutant of the human hsp7O promoter that retained basal activity was stimulated by these proteins (Table 1 ). There was some specificity to this stimulation; the hsp7O promoter was stimulated twice as much as the mouse metallothionein I promoter used as an internal control. Whether this specificity results from different sets of transcription factors recognizing the basal elements of these two promoters or instead reflects a contribution of a specific regulatory element within the human hsp7O promoter is not clear.
Identification of a novel promoter element. Why are there recognition sequences for polyomavirus large T antigen in the human hsp7O promoter? By constructing an artificial promoter in which the sequence of binding site 1 was inserted in place of the normal upstream promoter CAT box sequence, we demonstrate here that the binding site 1 sequence is capable of functioning as an upstream promoter element. Three sequence elements determine the ability of SV40 large T antigen to bind DNA; two pentanucleotides of the sequence 5'-GAGGC-3' and a spacer sequence (15, 29, 49, 53) . Polyomavirus large T antigen binding sites have a similar structure. The affinity of these proteins for any particular site appears to be partially dependent on the number of repeats of the pentanucleotide sequence (12, 49, 56) . Alteration of either pentanucleotide of hsp7O binding site 1 both eliminated polyomavirus large T binding (data not shown) and decreased the activity of the artificial promoter ( Fig. 6 and 7) . Alteration of both pentanucleotide sequences eliminated the ability of site 1 to function as an upstream element. Interestingly, mutation of hsp7O site 1 into SV40 site 1, primarily by altering the constitution of the 7-base spacer sequence, also reduced the strength of the artificial promoter. This latter sequence bound polyomavirus large T antigen efficiently (data not shown) but did not appear to function as an upstream sequence. These data offer a genetic argument that a cellular transcription factor exists that has an overlapping but not identical binding specificity to that of polyomavirus large T antigen.
What role might this sequence play in regulation of the human hsp7O promoter in vivo? It is clearly not necessary for basal activity of the promoter after transfection into established cell lines (Fig. 5) . The hsp7O promoter is regulated by numerous effects and is one of the earliest promoters turned on during embryonic development (3) . An attractive hypothesis is that different upstream transcription factors play a role in regulating the promoter in the numerous settings in which it is active; the cellular factor that recognizes hsp7O T antigen binding site 1 may be one of these factors.
